Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application(Sales & Marketing, Regulatory Compliance, R&D, Pharmacovigilance), Component(Software, Service), Delivery (On Premise, On Demand), End User -Global Forecast to 2027

Abstract
The life science analytics market is projected to reach USD 47.5 billion by 2027 from USD 27.1 billion in 2022, at a CAGR of 11.8% during the forecast period. Growth in this market is mainly driven by rising pressure to curb healthcare spending, the rising need for improved data standardization, and the increasing adoption of analytical solutions in clinical trials. On the other hand, a high implementation price is expected to restrain the growth of this market.

Descriptive analytics type segment holds the largest share of the life science analytics market in 2021”

On the basis of type, the life science analytics market is bifurcated into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment accounted for the largest market share in 2021. Due to its ability to confirm the synergistic integration of predictions and prescriptions, prescriptive analytics segment is projected to grow at the highest CAGR during the forecast period.

“Services segment accounted for the largest share of the life science analytics market in 2021.”

On the basis of component, the life science analytics market is bifurcated into services and software. The services segment accounted for the largest market share in 2021 and is expected to register the highest growth during the forecast period. The large share and high growth in this segment can be attributed to the frequent need for services such as software upgrades and maintenance.

“Asia Pacific to be the fastest-growing regional market in 2021.”

On the basis of region, the life science analytics market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2021, North America accounted for the largest market share. The large share of this market is attributed to the strong economies in the US and Canada, which have allowed for considerable investments in technology in this region. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as the rising adoption of advanced technologies, the increasing growth in the life science industry, and the growing focus of major players on increasing their presence in emerging APAC countries are expected to drive market growth in this regional segment.

The primary interviews conducted for this report can be categorized as follows:
•By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
•By Designation: C-level (30%), D-level (34%), and Others (36%)
•By Region: North America (40%), Europe (28%), Asia Pacific (20%), and the RoW (12%)

Prominent players in this market include Oracle (US), IBM (US), SAS Institute Inc. (US), Accenture (Ireland), IQVIA Inc, (US), Cognizant (US), Wipro (India), Allscripts Healthcare, LLC (US), Optum, Inc. (US), Microsoft (US), MaxisIT (US), ExlService Holdings, Inc. (US), Cerner Corporation (US), Cotiviti, Inc. (US), Inovalon (US), CitiusTech Inc (US), Saama Technologies, LLC. (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot Inc. (US), Alteryx, Inc. (US), Sisense Inc. (US), Amazon Web Services, Inc., and Veeva Systems (US).

Research Coverage:
This report provides a picture of the life science analytics market. It aims at estimating the size and future growth potential of the market across different segments, such as type, component, deployment model, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall life science analytics market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

Content
Table of Contents

1INTRODUCTION32
1.1STUDY OBJECTIVES32
1.2MARKET DEFINITION32
1.2.1INCLUSIONS AND EXCLUSIONS32
1.3MARKET SCOPE33
1.3.1MARKETS COVERED33
FIGURE 1LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION33
1.3.2YEARS CONSIDERED34
1.4CURRENCY CONSIDERED34
1.5STAKEHOLDERS34
1.6SUMMARY OF CHANGES34
1.7RECESSION IMPACT35
2RESEARCH METHODOLOGY36
2.1RESEARCH DATA36
2.2RESEARCH METHODOLOGY DESIGN36
FIGURE 2LIFE SCIENCE ANALYTICS MARKET: RESEARCH DESIGN36
2.2.1SECONDARY SOURCES37
2.2.1.1Key data from secondary sources37
2.2.2PRIMARY SOURCES38
FIGURE 3PRIMARY SOURCES38
2.2.2.1Key data from primary sources39
2.2.2.2Key industry insights40
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS40
2.3MARKET SIZE ESTIMATION41
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS41
FIGURE 6LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION42
FIGURE 7BOTTOM-UP APPROACH43
FIGURE 8LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)44
FIGURE 9CAGR PROJECTION: SUPPLY-SIDE ANALYSIS45
FIGURE 10TOP-DOWN APPROACH45
2.4MARKET BREAKDOWN AND DATA TRIANGULATION46
FIGURE 11DATA TRIANGULATION METHODOLOGY47
2.5MARKET SHARE ESTIMATION47
2.6STUDY ASSUMPTIONS48
2.7LIMITATIONS48
2.7.1METHODOLOGY-RELATED LIMITATIONS48
2.7.2SCOPE-RELATED LIMITATIONS48
2.8RISK ASSESSMENT49
TABLE 1LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT49
2.9LIFE SCIENCE ANALYTICS MARKET: RECESSION IMPACT49
3EXECUTIVE SUMMARY50
FIGURE 12LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)50
FIGURE 13LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)51
FIGURE 14LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)51
FIGURE 15LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2022 VS. 2027 (USD MILLION)52
FIGURE 16LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)52
FIGURE 17LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHICAL SNAPSHOT53
4PREMIUM INSIGHTS54
4.1LIFE SCIENCE ANALYTICS MARKET OVERVIEW54
FIGURE 18RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET54
4.2LIFE SCIENCE ANALYTICS MARKET, BY TYPE55
FIGURE 19DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE MARKET IN 202155
4.3LIFE SCIENCE ANALYTICS MARKET, BY END USER & REGION56
FIGURE 20PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 202156
4.4LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT57
FIGURE 21CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD57
5MARKET OVERVIEW58
5.1INTRODUCTION58
5.2MARKET DYNAMICS58
FIGURE 22LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES58
5.2.1DRIVERS59
5.2.1.1Rising pressure to curb healthcare spending59
FIGURE 23HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY (2019)59
5.2.1.2Rising need for improved data standardization60
5.2.1.3Rising technological advancements in analytical solutions60
5.2.1.4Impact of big data on life science61
5.2.1.5Growing adoption of analytical solutions in clinical trials61
5.2.1.6Increasing adoption of analytics for sales & marketing applications62
5.2.2RESTRAINTS62
5.2.2.1High implementation cost of advanced analytical solutions62
5.2.2.2Data privacy concerns62
5.2.3OPPORTUNITIES63
5.2.3.1Growing focus on value-based care63
5.2.3.2Use of analytics in precision & personalized medicine63
5.2.3.3Big data analytics for R&D productivity64
5.2.4CHALLENGES64
5.2.4.1Issues associated with data integration64
5.2.4.2Shortage of skilled personnel64
5.3ECOSYSTEM ANALYSIS65
5.4VALUE CHAIN ANALYSIS66
FIGURE 24LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS66
5.5PORTER’S FIVE FORCES ANALYSIS67
5.5.1THREAT FROM NEW ENTRANTS67
5.5.2THREAT FROM SUBSTITUTES68
5.5.3BARGAINING POWER OF SUPPLIERS68
5.5.4BARGAINING POWER OF BUYERS68
5.5.5INTENSITY OF COMPETITIVE RIVALRY68
5.6TECHNOLOGY ANALYSIS69
5.6.1MACHINE LEARNING69
5.6.2ARTIFICIAL INTELLIGENCE69
5.6.3INTERNET OF THINGS69
5.6.4BIG DATA69
5.7INDUSTRY TRENDS70
5.7.1INCREASING PARTNERSHIPS & COLLABORATIONS FOR INNOVATION70
5.7.2GROWING DEMAND FOR AI IN PHARMACEUTICAL INDUSTRY70
5.8CASE STUDY ANALYSIS71
5.8.1CASE STUDY 171
5.8.2CASE STUDY 271
5.8.3CASE STUDY 371
5.9REGULATORY ANALYSIS72
5.9.1NORTH AMERICA72
5.9.2EUROPE73
5.9.3ASIA PACIFIC73
5.9.4MIDDLE EAST & AFRICA74
5.9.5LATIN AMERICA74
5.10PRICING ANALYSIS74
TABLE 2AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION75
5.10.1AVERAGE SELLING PRICE TREND ANALYSIS75
 
5.11KEY CONFERENCES AND EVENTS IN 2022–202375
TABLE 3LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS75
5.12KEY STAKEHOLDERS AND BUYING CRITERIA76
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS76
FIGURE 25INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS76
TABLE 4INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)77
5.12.2BUYING CRITERIA77
FIGURE 26KEY BUYING CRITERIA FOR END USERS77
TABLE 5KEY BUYING CRITERIA FOR END USERS77
6LIFE SCIENCE ANALYTICS MARKET, BY TYPE78
6.1INTRODUCTION79
TABLE 6LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)79
6.2DESCRIPTIVE ANALYTICS79
6.2.1ABILITY TO BE IMPLEMENTED WITH STANDARD AGGREGATE FUNCTIONS TO DRIVE MARKET79
TABLE 7DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)80
TABLE 8NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)80
TABLE 9EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)80
TABLE 10ASIA PACIFIC: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)81
6.3PREDICTIVE ANALYTICS81
6.3.1SIMULATIONS DEVELOPMENT FOR PREDICTION OF FUTURE TRENDS TO DRIVE MARKET81
TABLE 11PREDICTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)82
TABLE 12NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)82
TABLE 13EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)82
TABLE 14ASIA PACIFIC: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)83
6.4PRESCRIPTIVE ANALYTICS83
6.4.1REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH83
TABLE 15PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)84
TABLE 16NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)84
TABLE 17EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)84
TABLE 18ASIA PACIFIC: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)85
 
7LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION86
7.1INTRODUCTION87
TABLE 19LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)87
7.2RESEARCH & DEVELOPMENT87
TABLE 20LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS88
TABLE 21LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)88
TABLE 22NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)89
TABLE 23EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)89
TABLE 24ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)89
TABLE 25LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)90
7.2.1CLINICAL TRIALS90
7.2.1.1Rising need to streamline clinical data and reduce time & costs to drive market90
TABLE 26LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS91
TABLE 27LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY REGION, 2020–2027 (USD MILLION)91
TABLE 28NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)91
TABLE 29EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)92
TABLE 30ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)92
7.2.2PRECLINICAL TRIALS92
7.2.2.1Ability to assist researchers in process innovation and decision support to drive adoption92
TABLE 31LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL TRIAL SOLUTIONS93
TABLE 32LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY REGION, 2020–2027 (USD MILLION)93
TABLE 33NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)93
TABLE 34EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)94
TABLE 35ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)94
 
7.3SALES & MARKETING94
7.3.1RISING ANALYSIS OF DIGITAL MARKETING EFFECTIVENESS TO DRIVE ADOPTION94
TABLE 36LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS95
TABLE 37LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY REGION, 2020–2027 (USD MILLION)95
TABLE 38NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020–2027 (USD MILLION)96
TABLE 39EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020–2027(USD MILLION)96
TABLE 40ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020–2027 (USD MILLION)96
7.4PHARMACOVIGILANCE97
7.4.1MONITORING OF DRUG TRIALS AND MEDICATION PROGRAMS TO FUEL MARKET UPTAKE97
TABLE 41LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS97
TABLE 42LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2020–2027 (USD MILLION)97
TABLE 43NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION)98
TABLE 44EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION)98
TABLE 45ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION)98
7.5REGULATORY COMPLIANCE99
7.5.1STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION OF SOLUTIONS99
TABLE 46LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS99
TABLE 47LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2020–2027 (USD MILLION)99
TABLE 48NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027(USD MILLION)100
TABLE 49EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027 (USD MILLION)100
TABLE 50ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027 (USD MILLION)100
7.6SUPPLY CHAIN OPTIMIZATION101
7.6.1RISING NEED TO REDUCE LOGISTICS COSTS TO SUPPORT MARKET GROWTH101
TABLE 51LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS101
TABLE 52LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY REGION, 2020–2027 (USD MILLION)101
TABLE 53NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION)102
TABLE 54EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION)102
TABLE 55ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION)102
8LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT103
8.1INTRODUCTION104
TABLE 56LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027(USD MILLION)104
8.2SERVICES104
8.2.1INCREASING UTILIZATION OF SERVICE PROVIDERS FOR IMPLEMENTATION AND MAINTENANCE OF ANALYTICS TO DRIVE MARKET104
TABLE 57LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)105
TABLE 58NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)105
TABLE 59EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)106
TABLE 60ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)106
8.3SOFTWARE106
8.3.1RISING NEED TO MANAGE CLINICAL TRIALS DATA BY PHARMA-BIOTECH COMPANIES TO DRIVE ADOPTION106
TABLE 61LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)107
TABLE 62NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 63EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 64ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
9LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL109
9.1INTRODUCTION110
TABLE 65LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)110
9.2ON-PREMISE DELIVERY MODEL110
9.2.1PROVISION OF MULTI-VENDOR ARCHITECTURE AND SECURITY BENEFITS TO DRIVE MARKET110
TABLE 66LIFE SCIENCE ANALYTICS MARKET FOR ON-PREMISE DELIVERY MODEL, BY REGION, 2020–2027 (USD MILLION)111
TABLE 67NORTH AMERICA: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 68EUROPE: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 69ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)112
 
9.3ON-DEMAND DELIVERY MODEL112
9.3.1REAL-TIME ANALYSIS AND ELIMINATION OF PURCHASING COSTS FOR SOFTWARE & HARDWARE TO DRIVE ADOPTION112
TABLE 70LIFE SCIENCE ANALYTICS MARKET: ON-DEMAND SOLUTIONS OFFERED113
TABLE 71LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY REGION, 2020–2027 (USD MILLION)113
TABLE 72NORTH AMERICA: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 73EUROPE: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 74ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)114
10LIFE SCIENCE ANALYTICS MARKET, BY END USER115
10.1INTRODUCTION116
TABLE 75LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)116
10.2PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES116
10.2.1RISING NEED FOR INNOVATIVE THERAPIES TO ADOPT ANALYTICS FOR PRODUCT DEVELOPMENT116
TABLE 76LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)117
TABLE 77NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 78EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 79ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)118
10.3MEDICAL DEVICE COMPANIES119
10.3.1ADOPTION OF BIG DATA ANALYTICS FOR COMMERCIALIZATION OF DEVICES TO DRIVE MARKET119
TABLE 80LIFE SCIENCE ANALYTICS MARKET: KEY SOLUTIONS OFFERED BY COMPANIES119
TABLE 81LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2020–2027 (USD MILLION)119
TABLE 82NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 83EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)120
TABLE 84ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)120
10.4RESEARCH CENTERS120
10.4.1ANALYZATION OF LARGE VOLUMES OF DATA DUE TO INCREASING RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH120
TABLE 85LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION)121
TABLE 86NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 87EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 88ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)122
10.5THIRD-PARTY ADMINISTRATORS (TPAS)122
10.5.1RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET GROWTH122
TABLE 89LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2020–2027 (USD MILLION)122
TABLE 90NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION)123
TABLE 91EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION)123
TABLE 92ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION)123
11LIFE SCIENCE ANALYTICS MARKET, BY REGION124
11.1INTRODUCTION125
TABLE 93LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)125
11.2NORTH AMERICA125
FIGURE 27NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT126
11.2.1NORTH AMERICA: RECESSION IMPACT ANALYSIS127
TABLE 94NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 95NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 96NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)128
TABLE 97NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 98NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)128
TABLE 99NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)129
TABLE 100NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)129
11.2.2US129
11.2.2.1Established economy and increasing R&D expenditure to drive adoption of analytical solutions129
TABLE 101US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)130
TABLE 102US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)131
TABLE 103US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 104US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)131
TABLE 105US: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)132
TABLE 106US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)132
11.2.3CANADA132
11.2.3.1Rising need for data standardization in life sciences to fuel uptake132
TABLE 107CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)133
TABLE 108CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)133
TABLE 109CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 110CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)134
TABLE 111CANADA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)134
TABLE 112CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)135
11.3EUROPE135
11.3.1EUROPE: RECESSION IMPACT ANALYSIS135
TABLE 113EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 114EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)136
TABLE 115EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)136
TABLE 116EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)137
TABLE 117EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)137
TABLE 118EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)137
TABLE 119EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)138
11.3.2GERMANY138
11.3.2.1Growing R&D investments by pharmaceutical & biotechnology companies to drive market138
TABLE 120GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)139
TABLE 121GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)139
TABLE 122GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)139
TABLE 123GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)140
TABLE 124GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)140
TABLE 125GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)140
 
11.3.3FRANCE141
11.3.3.1Growing government support for adoption of AI & big data analytics to drive market141
TABLE 126FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)141
TABLE 127FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)142
TABLE 128FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)142
TABLE 129FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)142
TABLE 130FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027(USD MILLION)143
TABLE 131FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)143
11.3.4UK143
11.3.4.1Growing number of clinical trials to drive uptake of life science analytics solutions143
TABLE 132UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 133UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)144
TABLE 134UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 135UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)145
TABLE 136UK: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)145
TABLE 137UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)145
11.3.5ITALY146
11.3.5.1Growing number of drug approvals to drive uptake of analytics solutions146
TABLE 138ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 139ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)146
TABLE 140ITALY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 141ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)147
TABLE 142ITALY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027(USD MILLION)147
TABLE 143ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)147
11.3.6REST OF EUROPE148
TABLE 144REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 145REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)148
TABLE 146REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)149
TABLE 147REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)149
TABLE 148REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)149
TABLE 149REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)150
11.4ASIA PACIFIC150
FIGURE 28ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT151
11.4.1ASIA PACIFIC: RECESSION IMPACT ANALYSIS151
TABLE 150ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
TABLE 151ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 152ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)153
TABLE 153ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)153
TABLE 154ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)153
TABLE 155ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)154
TABLE 156ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)154
11.4.2JAPAN154
11.4.2.1Growing government support for clinical R&D activities to drive adoption154
TABLE 157JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 158JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)155
TABLE 159JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 160JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)156
TABLE 161JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)156
TABLE 162JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)156
11.4.3CHINA157
11.4.3.1Growth in life science industry to support adoption of solutions157
TABLE 163CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)157
TABLE 164CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)158
TABLE 165CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)158
TABLE 166CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)158
TABLE 167CHINA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)159
TABLE 168CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)159
11.4.4INDIA159
11.4.4.1Rising R&D expenditure and growing number of drug development activities to support market growth159
TABLE 169INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 170INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)160
TABLE 171INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)161
TABLE 172INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)161
TABLE 173INDIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)161
TABLE 174INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)161
11.4.5REST OF ASIA PACIFIC162
TABLE 175REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 176REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)162
TABLE 177REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 178REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)163
TABLE 179REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)163
TABLE 180REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)164
11.5REST OF THE WORLD164
11.5.1REST OF THE WORLD: RECESSION IMPACT ANALYSIS164
TABLE 181REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)165
TABLE 182REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)166
TABLE 183REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 184REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)166
TABLE 185REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)167
TABLE 186REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)167
12COMPETITIVE LANDSCAPE168
12.1INTRODUCTION168
12.2STRATEGIES ADOPTED BY KEY PLAYERS168
12.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS169
12.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS170
FIGURE 29LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS170
12.4MARKET RANKING ANALYSIS, 2021171
FIGURE 30LIFE SCIENCE ANALYTICS MARKET: MARKET RANKING ANALYSIS (2021)171
12.5COMPETITIVE LEADERSHIP MAPPING172
12.5.1STARS172
12.5.2PERVASIVE PLAYERS172
12.5.3EMERGING LEADERS172
12.5.4PARTICIPANTS172
FIGURE 31COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021)173
12.6COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS173
12.6.1PROGRESSIVE COMPANIES173
12.6.2STARTING BLOCKS173
12.6.3RESPONSIVE COMPANIES174
12.6.4DYNAMIC COMPANIES174
FIGURE 32COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2021)174
12.7COMPETITIVE BENCHMARKING175
TABLE 187LIFE SCIENCE ANALYTICS MARKET: OVERALL COMPANY FOOTPRINT175
TABLE 188LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT OF COMPANIES175
TABLE 189LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT OF COMPANIES176
TABLE 190LIFE SCIENCE ANALYTICS MARKET: REGIONAL FOOTPRINT OF COMPANIES176
12.8COMPETITIVE SCENARIO176
12.8.1PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS177
TABLE 191KEY PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS (JANUARY 2019─DECEMBER 2022)177
12.8.2DEALS178
TABLE 192DEALS (JANUARY 2019─DECEMBER 2022)178
12.8.3OTHER DEVELOPMENTS179
TABLE 193OTHER DEVELOPMENTS (JANUARY 2019─DECEMBER 2022)179
 
13COMPANY PROFILES180
13.1KEY PLAYERS180
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1ORACLE180
TABLE 194ORACLE: COMPANY OVERVIEW180
FIGURE 33ORACLE: COMPANY SNAPSHOT (2022)181
13.1.2IBM184
TABLE 195IBM: COMPANY OVERVIEW184
FIGURE 34IBM: COMPANY SNAPSHOT (2021)185
13.1.3SAS INSTITUTE INC.188
TABLE 196SAS INSTITUTE INC.: COMPANY OVERVIEW188
FIGURE 35SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021)189
13.1.4ACCENTURE192
TABLE 197ACCENTURE: COMPANY OVERVIEW192
FIGURE 36ACCENTURE: COMPANY SNAPSHOT (2021)193
13.1.5IQVIA INC.196
TABLE 198IQVIA INC.: COMPANY OVERVIEW196
FIGURE 37IQVIA INC.: COMPANY SNAPSHOT (2021)197
13.1.6COGNIZANT201
TABLE 199COGNIZANT: COMPANY OVERVIEW201
FIGURE 38COGNIZANT: COMPANY SNAPSHOT (2021)202
13.1.7WIPRO205
TABLE 200WIPRO: COMPANY OVERVIEW205
FIGURE 39WIPRO: COMPANY SNAPSHOT (2022)206
13.1.8ALLSCRIPTS HEALTHCARE, LLC209
TABLE 201ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW209
FIGURE 40ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)210
13.1.9OPTUM, INC.212
TABLE 202OPTUM, INC.: COMPANY OVERVIEW212
FIGURE 41OPTUM, INC.: COMPANY SNAPSHOT (2021)212
13.1.10MICROSOFT214
TABLE 203MICROSOFT: COMPANY OVERVIEW214
FIGURE 42MICROSOFT: COMPANY SNAPSHOT (2021)215
13.1.11MAXISIT218
TABLE 204MAXISIT: COMPANY OVERVIEW218
13.1.12EXLSERVICE HOLDINGS, INC.220
TABLE 205EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW220
FIGURE 43EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021)221
13.1.13CERNER CORPORATION223
TABLE 206CERNER CORPORATION: COMPANY OVERVIEW223
FIGURE 44CERNER CORPORATION: COMPANY SNAPSHOT (2021)224
13.1.14INOVALON226
TABLE 207INOVALON: COMPANY OVERVIEW226
13.1.15CITIUSTECH INC.228
TABLE 208CITIUSTECH INC.: COMPANY OVERVIEW228
13.1.16SAAMA TECHNOLOGIES, LLC230
TABLE 209SAAMA TECHNOLOGIES, LLC: COMPANY OVERVIEW230
13.1.17AXTRIA233
TABLE 210AXTRIA: COMPANY OVERVIEW233
13.1.18CLARIVATE235